These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 14907426)
21. [Clinical research on pangamic acid]. LEONE M; LONGARETTI A; LUCCHELLI P Minerva Med; 1957 Oct; 48(83):3438-40. PubMed ID: 13493201 [No Abstract] [Full Text] [Related]
22. Pangamic acid ("vitamin B15"). Herbert V Am J Clin Nutr; 1979 Jul; 32(7):1534-40. PubMed ID: 377937 [No Abstract] [Full Text] [Related]
23. [Pangamic acid in migraine]. Heyck H Dtsch Med Wochenschr; 1969 Apr; 94(16):867. PubMed ID: 5776719 [No Abstract] [Full Text] [Related]
24. [Comparative clinical evaluation of the effects of the hypothetical octamethyl pangamic acid & dichloroethanoate of diisopropylammonium in dermatological pathology]. RANDAZZO SD Rass Dermatol Sifilogr; 1958; 11(2):83-92. PubMed ID: 13591563 [No Abstract] [Full Text] [Related]
25. [Use of pangamic acid in hyperlipidemia]. Czaplicki S; Michajlik A; Sulek K Pol Tyg Lek; 1976 Mar; 31(11):451-2. PubMed ID: 1272928 [No Abstract] [Full Text] [Related]
26. Pangamic acid in cerebral damages induced by sclerotic vasculopathy. BENATI E Boll Soc Ital Biol Sper; 1957 Jun; 33(6):930-2. PubMed ID: 13499747 [No Abstract] [Full Text] [Related]
27. [B vitamins are not suitable for secondary prevention of cardiovascular disease]. Heinzl S Med Monatsschr Pharm; 2005 Nov; 28(11):373. PubMed ID: 16309020 [No Abstract] [Full Text] [Related]
28. [Cardiology -- an update]. Hoppe UC; Erdmann E Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1435-7. PubMed ID: 16794969 [No Abstract] [Full Text] [Related]
29. Homocysteine, B-vitamins, and the risk of cardiovascular disease. Clarke R; Smulders Y; Fowler B; Stehouwer CD Semin Vasc Med; 2005 May; 5(2):75-6. PubMed ID: 16047260 [No Abstract] [Full Text] [Related]
31. FDA notes lack of evidence on pangamic acid claims. FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):38. PubMed ID: 720793 [No Abstract] [Full Text] [Related]
33. [Group B vitamins as new variables related to the cardiovascular risk]. Granieri M; Bellisarii FI; De Caterina R Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726 [TBL] [Abstract][Full Text] [Related]
34. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738 [TBL] [Abstract][Full Text] [Related]
35. [Folate therapy for prevention of cardiovascular risk in uremia]. Perna A G Ital Nefrol; 2008; 25(3):273. PubMed ID: 18473294 [No Abstract] [Full Text] [Related]
36. [The effect of pangamic acid on the course of larval ascariasis and riboflavin levels in the liver of guinea pigs]. Jabłonowski Z; Sudoł K Wiad Parazytol; 1987; 33(6):635-42. PubMed ID: 3454497 [No Abstract] [Full Text] [Related]
37. [Polyvital as the basic therapy of the B-complex treatment of cardiac patients]. STEIDLE R Med Klin; 1955 Dec; 50(52):2199-200. PubMed ID: 13296770 [No Abstract] [Full Text] [Related]
38. [Existence of "pangamic acid" alias "vitamin B 15"?]. Riemschneider R; Quelle G Fortschr Med; 1984 Mar; 102(12):339-41. PubMed ID: 6714908 [TBL] [Abstract][Full Text] [Related]